National Healthcare Properties (NHP) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
31 May, 2026Executive summary
Internalization of management in late 2024 led to improved asset performance, transparency, and reduced leverage, eliminating related party fees and transitioning to self-management.
Same Store Cash NOI reached $32M in Q3 2025, reflecting 12.2% year-over-year growth, driven by strong SHOP and OMF asset performance.
Net loss attributable to common stockholders was $15.9 million for Q3 2025, a significant improvement from $44.1 million in Q3 2024, driven by lower expenses and higher gains on property sales.
Portfolio consists of 174 properties in 30 states, with 7.3 million rentable square feet, 63% of cash NOI from OMF and 37% from SHOP.
Significant progress made toward public listing, including asset dispositions and IPO preparations.
Financial highlights
Adjusted FFO reached $10.4 million ($0.36/share) in Q3 2025, up $0.04 sequentially and from $7.9M in Q3 2024.
Nareit-defined FFO was $6.7 million ($0.23/share), up $0.04 from prior quarter; FFO per share rose 21.1% quarter-over-quarter.
Net operating income (NOI) for Q3 2025 was $32.2 million, nearly flat year-over-year.
Net leverage reduced to 4.8x Net Debt to Annualized Adjusted EBITDA, down from 13.7x a year ago.
Total revenue from tenants was $86.0 million in Q3 2025, down from $88.9 million in Q3 2024, mainly due to property dispositions.
Outlook and guidance
Momentum expected to continue in Q4, with September spot occupancy at 84.9% in SHOP and management focused on further reducing leverage.
Anticipates closing an unsecured corporate credit facility in Q4 2025 or Q1 2026, followed by IPO preparations.
Sufficient liquidity is anticipated to meet financial obligations for at least the next twelve months, with funding from cash on hand, operations, property dispositions, and potential new financings.
Latest events from National Healthcare Properties
- Q2 AFFO rose 13.8% to $4.4M, but a $98.2M fee drove a $119.9M net loss; internalization underway.NHP
Q2 202431 May 2026 - AFFO per share up 5x YoY, leverage improved, and SHOP segment delivered strong NOI growth.NHP
Q1 202531 May 2026 - Normalized FFO per share jumped 163% as senior housing NOI soared and leverage improved.NHP
Q4 202531 May 2026 - Q2 2025 saw robust NOI growth, improved leverage, and enhanced liquidity from asset sales.NHP
Q2 202531 May 2026 - AFFO up 26.4% YoY to $1.9M; internalization, dispositions, and reverse split improved efficiency.NHP
Q3 202431 May 2026 - Q4 2024 AFFO soared 576% year-over-year, with leverage and portfolio quality significantly improved.NHP
Q4 202428 May 2026 - Strong NOI growth, higher occupancy, and lower leverage drive robust performance and outlook.NHP
Investor presentation28 May 2026 - All proposals passed, board re-elected, and auditor ratified at the annual meeting.NHP
AGM 202618 May 2026 - IPO proceeds drove strong FFO growth, improved leverage, and a shift to senior housing.NHP
Q1 202614 May 2026